Provid Pharmaceuticals Inc is categorized under Commercial Medical Research in Monmouth Junction, NJ and active since 1998.
Provid Pharmaceuticals Inc was established in 1998, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Gary L Olson at the company’s single location by writing to 7 Deerpark Drive # D, Monmouth Junction, New Jersey NJ 08852 or by phoning (732) 823-1488. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Provid Pharmaceuticals Inc |
| Contact Person: | Gary L Olson |
| Address: | 7 Deerpark Drive # D, Monmouth Junction, New Jersey 08852 |
| Phone Number: | (732) 823-1488 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1998 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Provid Pharmaceuticals Inc was started in 1998 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Gary L Olson for inquiries that concern Provid Pharmaceuticals Inc by calling the company number (732) 823-1488, as your correspondence is most welcome. Additionally, the physical location of the single location of Provid Pharmaceuticals Inc can be found at the coordinates as well as the street address 7 Deerpark Drive # D in Monmouth Junction, New Jersey 08852.
For its online presence, you may visit Provid Pharmaceuticals Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.